Skip NavigationSkip to Content

Minimal PD-1 expression in mouse and human NK cells under diverse conditions

  1. Author:
    Judge, Sean J.
    Dunai, Cordelia
    Aguilar, Ethan G.
    Vick, Sarah C.
    Sturgill, Ian R.
    Khuat, Lam T.
    Stoffel, Kevin M.
    Van Dyke, Jonathan
    Longo, Dan L.
    Darrow, Morgan A.
    Anderson,Steve
    Blazar, Bruce R.
    Monjazeb, Arta M.
    Serody, Jonathan S.
    Canter, Robert J.
    Murphy, William J.
  2. Author Address

    UCD, Dept Surg, Sacramento, CA USA.UCD, Dept Dermatol, Sacramento, CA USA.Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC USA.UCD, Flow Cytometry Core, Sacramento, CA USA.Harvard Med Sch, Dept Med, Boston, MA 02115 USA.UCD, Dept Pathol & Lab Med, Sacramento, CA USA.Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Mol Immunol Sect, Frederick, MD USA.Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA.Univ Minnesota, Dept Pediat, Div Blood & Bone Marrow Transplantat, Minneapolis, MN 55455 USA.UCD, Dept Radiat Oncol, Sacramento, CA USA.Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA.Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC USA.UCD, Dept Med, Sacramento, CA USA.
    1. Year: 2020
    2. Date: JUN 1
  1. Journal: JOURNAL OF CLINICAL INVESTIGATION
  2. AMER SOC CLINICAL INVESTIGATION INC,
    1. 130
    2. 6
    3. Pages: 3051-3068
  3. Type of Article: Article
  4. ISSN: 0021-9738
  1. Abstract:

    PD-1 expression is a hallmark of both early antigen-specific T cell activation and later chronic stimulation, suggesting key roles in both naive T cell priming and memory T cell responses. Although significant similarities exist between T cells and NK cells, there are critical differences in their biology and functions reflecting their respective adaptive and innate immune effector functions. Expression of PD-1 on NK cells is controversial despite rapid incorporation into clinical cancer trials. Our objective was to stringently and comprehensively assess expression of PD-1 on both mouse and human NK cells under multiple conditions and using a variety of readouts. We evaluated NK cells from primary human tumor samples, after ex vivo culturing, and from multiple mouse tumor and viral models using flow cytometry, quantitative reverse-transcriptase PCR (qRT-PCR), and RNA-Seq for PD-1 expression. We demonstrate that, under multiple conditions, human and mouse NI< cells consistently lack PD-1 expression despite the marked upregulation of other activation/regulatory markers, such as TIGIT. This was in marked contrast to T cells, which were far more prominent within all tumors and expressed PD-1. These data have important implications when attempting to discern NK from T cell effects and to determine whether PD-1 targeting can be expected to have direct effects on NK cell functions.

    See More

External Sources

  1. DOI: 10.1172/JCI33353
  2. WOS: 000544332600040

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel